Pataday and Nasacort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pataday (olopatadine hydrochloride) and Nasacort (triamcinolone acetonide). Common drug interactions include ocular discomfort among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Pataday and Nasacort. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

On Jul, 19, 2026

52 people who take Pataday and Nasacort together, and have interactions are studied.

What are the common drug interactions of Pataday and Nasacort, by gender? *:

female:

Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteoporosis (bones weak and more likely to break)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Peripheral swelling
Cough
Abdominal pain
Asthma
Hypersensitivity
Pruritus (severe itching of the skin)

male:

Chronic kidney disease
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Renal failure (kidney dysfunction)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Sepsis (a severe blood infection that can lead to organ failure and death)
Skin exfoliation (removal of the oldest dead skin cells)
Asthenia (weakness)
Cardiomyopathy (weakening of the heart muscle)
Diarrhoea
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Pataday and Nasacort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Arthralgia (joint pain)
Headache (pain in head)
Pruritus (severe itching of the skin)
Chest discomfort
Chest pain
Chronic kidney disease
Dry mouth
Dry skin
Dyspnoea (difficult or laboured respiration)
Ear discomfort

40-49:

Abdominal pain
Cough
Hypersensitivity
Asthma
Anaphylactic reaction (serious allergic reaction)
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)
Vulvovaginal mycotic infection (vulvovaginal fungal infection)

50-59:

Hypoaesthesia (reduced sense of touch or sensation)
Adverse drug reaction
Back pain
Burning sensation
Dysphonia (speech disorder attributable to a disorder of phonation)
Erythema (redness of the skin)
Hepatitis b
Insomnia (sleeplessness)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Peripheral swelling

60+:

Chronic kidney disease
Drug ineffective
Colitis (inflammation of colon)
Cyst (a closed sac)
Diarrhoea
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Dyspnoea (difficult or laboured respiration)
Fluid intake reduced
Headache (pain in head)
Hypersensitivity

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 26.92%
Asthma: 10 people, 19.23%
Hypersensitivity: 9 people, 17.31%
Pain: 8 people, 15.38%
Depression: 6 people, 11.54%
Stress And Anxiety: 5 people, 9.62%
Sinusitis (inflammation of sinus): 5 people, 9.62%
Rickets (softening of bones): 5 people, 9.62%
Immunodeficiency Common Variable: 5 people, 9.62%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take Pataday and Nasacort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously